Farther Finance Advisors’s Takeda Pharmaceutical TAK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $86.9K | Buy |
5,623
+1,003
| +22% | +$15.5K | ﹤0.01% | 1823 |
|
|
2025
Q1 | $68.8K | Buy |
4,620
+1,045
| +29% | +$15.6K | ﹤0.01% | 1721 |
|
|
2024
Q4 | $47.3K | Buy |
3,575
+1,976
| +124% | +$26.2K | ﹤0.01% | 1688 |
|
|
2024
Q3 | $22.7K | Buy |
1,599
+238
| +17% | +$3.38K | ﹤0.01% | 2028 |
|
|
2024
Q2 | $17.7K | Buy |
1,361
+325
| +31% | +$4.23K | ﹤0.01% | 1821 |
|
|
2024
Q1 | $14.2K | Sell |
1,036
-632
| -38% | -$8.64K | ﹤0.01% | 1618 |
|
|
2023
Q4 | $23.8K | Buy |
1,668
+867
| +108% | +$12.4K | ﹤0.01% | 1289 |
|
|
2023
Q3 | $12.4K | Buy |
801
+733
| +1,078% | +$11.3K | ﹤0.01% | 1223 |
|
|
2023
Q2 | $1.07K | Hold |
68
| – | – | ﹤0.01% | 1956 |
|
|
2023
Q1 | $1.12K | Hold |
68
| – | – | ﹤0.01% | 1820 |
|
|
2022
Q4 | $1.06K | Buy |
+68
| New | +$1.06K | ﹤0.01% | 1636 |
|